BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 16077926)

  • 1. Loss of endogenous Nfatc1 reduces the rate of DMBA/TPA-induced skin tumorigenesis.
    Goldstein J; Roth E; Roberts N; Zwick R; Lin S; Fletcher S; Tadeu A; Wu C; Beck A; Zeiss C; Suárez-Fariñas M; Horsley V
    Mol Biol Cell; 2015 Oct; 26(20):3606-14. PubMed ID: 26310443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARC and the N-propeptide of collagen I influence fibroblast proliferation and collagen assembly in the periodontal ligament.
    Rosset EM; Trombetta-eSilva J; Hepfer G; Yao H; Bradshaw AD
    PLoS One; 2017; 12(2):e0173209. PubMed ID: 28245286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone.
    Chlenski A; Guerrero LJ; Salwen HR; Yang Q; Tian Y; Morales La Madrid A; Mirzoeva S; Bouyer PG; Xu D; Walker M; Cohn SL
    PLoS One; 2011; 6(9):e23880. PubMed ID: 21949685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDB2 gene disruption leads to skin tumors and resistance to apoptosis after exposure to ultraviolet light but not a chemical carcinogen.
    Itoh T; Cado D; Kamide R; Linn S
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2052-7. PubMed ID: 14769931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
    Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
    Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
    Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
    Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
    Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
    Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
    Basu A; Rodeck U; Prendergast GC; Howe CC
    Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced excision repair cross-complementing 1 expression associates with enhanced papilloma formation and fibroblast transformation after genetic disruption of secreted protein acidic and rich in cysteine.
    Kato Y; Tsukuda M; Nagashima Y; Koshika S; Sakai N; Yao M; Kubota Y; Aoki I; Colledge WH; Foidart JM; Hata R; Thompson EW
    Int J Oncol; 2005 Sep; 27(3):759-68. PubMed ID: 16077926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
    Stern MC; Conti CJ
    Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983
    [No Abstract]   [Full Text] [Related]  

  • 12. Hevin/SC1, a matricellular glycoprotein and potential tumor-suppressor of the SPARC/BM-40/Osteonectin family.
    Sullivan MM; Sage EH
    Int J Biochem Cell Biol; 2004 Jun; 36(6):991-6. PubMed ID: 15094114
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.